SCHEMBL23342008

SCHEMBL23342008

Cc1ccc2c(c1)c1cc(C)ccc1n2-c1c(C#N)c(-n2c3ccc(C)cc3c3cc(C)ccc32)c(-n2c3ccc(C)cc3c3cc(C)ccc32)c(-n2c3ccc(C)cc3c3cc(C)ccc32)c1-c1cccnc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 4/20 0.45
CYP11B1 P15538 1/20 0.45
MAOA P21397 1/20 0.45
KDM4E B2RXH2 5/20 0.43
HSD17B10 Q99714 2/20 0.43
HTT P42858 1/20 0.43
RXFP1 Q9HBX9 1/20 0.41
MAP2K4 P45985 1/20 0.41
TSHR P16473 2/20 0.40
MAPK1 P28482 2/20 0.40
ALDH1A1 P00352 2/20 0.40
CYP2A6 P11509 1/20 0.39
DYRK1A Q13627 2/20 0.37
MAPT P10636 1/20 0.37
HPGD P15428 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
ADORA1 P30542 2/20 0.36
GLA P06280 1/20 0.36
GAA P10253 1/20 0.36
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23342564 0.96 CYP11B2 (0.48) CYP11B2CYP11B1MAOAKDM4EHSD17B10
SCHEMBL31273534 0.94 CYP11B2 (0.46) CYP11B2CYP11B1MAOAKDM4EHSD17B10
SCHEMBL31273497 0.90 CYP11B2 (0.49) CYP11B2CYP11B1MAOAKDM4EHSD17B10
SCHEMBL31272879 0.89 CYP11B2 (0.43) CYP11B2CYP11B1MAOAKDM4EHSD17B10
SCHEMBL31273426 0.87 CYP11B2 (0.43) CYP11B2CYP11B1MAOAKDM4EHSD17B10
SCHEMBL23296391 0.86 KDM4E (0.36) CYP11B2CYP11B1MAOAKDM4EHSD17B10
SCHEMBL31273156 0.84 CYP11B2 (0.54) CYP11B2CYP11B1MAOAKDM4EHSD17B10
SCHEMBL31273455 0.84 CYP11B2 (0.43) CYP11B2CYP11B1MAOAKDM4EHSD17B10
SCHEMBL23629578 0.84 KIF11 (0.44) CYP11B2CYP11B1MAOAKDM4EHSD17B10
SCHEMBL23296336 0.84 CYP11B2 (0.46) CYP11B2CYP11B1MAOAKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210135119-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX, INC. (JP) 2021-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210135119-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, SLCO1B3, NDUFV3 CYP11B2 1221/4885CYP11B1 1903/4885MAOA 123/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.